Showing 1 - 10 of 46
Persistent link: https://www.econbiz.de/10004255316
Persistent link: https://www.econbiz.de/10010952662
Persistent link: https://www.econbiz.de/10010952684
Persistent link: https://www.econbiz.de/10010952709
The moral prohibition against theft, and legal causes of action against trespass and like activities, are usually stated in absolutist terms that admit few exceptions. But application of the theft prohibition to creative goods is incomplete and unstable across industries, regions and periods....
Persistent link: https://www.econbiz.de/10014183048
The incentive thesis for patents is challenged by the existence of alternative means by which firms can capture returns on innovation. Taking into account patent alternatives yields a robust reformulation of the incentive thesis as mediated by organizational form. Patents enable innovators to...
Persistent link: https://www.econbiz.de/10014194299
We typically assume that intellectual property makes a substantial difference in regulating access to intellectual goods and thereby provides incentives for the production of intellectual goods. But the existence of alternative instruments by which to appropriate innovation returns suggests that...
Persistent link: https://www.econbiz.de/10014204153
It is commonly asserted that innovation markets suffer from excessive intellectual property protections, which in turn stifle output. But empirical inquiries can neither confirm nor deny this assertion. Under the "agnostic" assumption that we cannot assess directly whether intellectual-property...
Persistent link: https://www.econbiz.de/10014214363
Judicial decisions, agency actions and legislative enactments have promoted a creeping reversion toward the weak patent regime that prevailed for several decades preceding the establishment of the Court of Appeals for the Federal Circuit. The pending Supreme Court case, Oil States Energy...
Persistent link: https://www.econbiz.de/10014115194
It is common to characterize patents as monopolies. This assumption, which underlies the standard dichotomy between intellectual property and antitrust law, is challenged by evidence that large companies in technology markets (outside biopharmaceuticals) tend to advocate for weaker patent...
Persistent link: https://www.econbiz.de/10014080393